Christopher Means

Christopher Means is vice president of R&D partnerships at Vizient, where he's focused on helping health systems adopt and scale AI capabilities. His work centers on translating AI strategy into practical governance, operating models, and measurable outcomes. Means has over 20 years of experience in strategy and transformation, including as a partner at Boston Consulting Group, where he led engagements across healthcare and financial services.